scispace - formally typeset
R

Rainer Storb

Researcher at Fred Hutchinson Cancer Research Center

Publications -  912
Citations -  61210

Rainer Storb is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Transplantation & Total body irradiation. The author has an hindex of 123, co-authored 905 publications receiving 58780 citations. Previous affiliations of Rainer Storb include Kanazawa University & Pacific Northwest National Laboratory.

Papers
More filters
Journal ArticleDOI

Chronic graft-versus-host syndrome in man: A long-term clinicopathologic study of 20 seattle patients

TL;DR: Three patients had limited chronic GVHD with relatively favorable prognosis characterized by localized skin involvement and/or hepatic disease without chronic aggressive histology, but most patients, however, had extensive disease with a progressive course.
Journal ArticleDOI

Evidence for Circulating Bone Marrow-Derived Endothelial Cells

TL;DR: It is demonstrated that a subset of CD34(+) cells have the capacity to differentiate into endothelial cells in vitro in the presence of basic fibroblast growth factor, insulin-like growth factor-1, and vascular endothelial growth factor.
Journal ArticleDOI

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

TL;DR: In patients given high-dose chemotherapy, with or without radiation, for the treatment of hematologic cancer,allogeneic peripheral-blood cells used for hematopoietic rescue restore blood counts faster than allogeneic bone marrow, without increasing the risk of graft-versus-host disease.
Journal ArticleDOI

Pregnancies following high-dose cyclophosphamide with or without high- dose busulfan or total-body irradiation and bone marrow transplantation

TL;DR: Pregnancies among all women who received a marrow transplant are likely to be accompanied by preterm labor and delivery of LBW or VLBW babies who do not seem to be at an increased risk of congenital anomalies, but determination of possible adverse effects of parental exposure to high-dose alkylating agents with or without TBI on children born posttransplant requires longer, additional follow-up.